Australia's most trusted
source of pharma news
Sunday, 05 October 2025
Posted 1 October 2025 AM
Pfizer is first off the bat to make a deal with the US Government to lower the price of the drugs it sells to Medicaid, as America tries to "retrain" other countries to pay higher prices.
Pfizer CEO Albert Bourla joined US President Donald Trump and other high-ranking health officials in the Oval Office to announce the deal, arguably the biggest win for Trump in his second term - and one that could have a drastic impact on access to medicines in Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.